LANDOS BIOPHARMA INC's ticker is LABP and the CUSIP is 515069102. A total of 46 filers reported holding LANDOS BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $384 | -92.3% | 768 | -91.1% | 0.00% | – |
| Q3 2022 | $5,000 | -37.5% | 8,653 | -10.3% | 0.00% | – |
| Q2 2022 | $8,000 | -27.3% | 9,649 | +32.9% | 0.00% | – |
| Q1 2022 | $11,000 | -98.5% | 7,260 | -95.3% | 0.00% | – |
| Q4 2021 | $738,000 | +2738.5% | 153,776 | +8722.5% | 0.00% | – |
| Q3 2021 | $26,000 | -67.9% | 1,743 | -74.8% | 0.00% | – |
| Q2 2021 | $81,000 | +1520.0% | 6,912 | +1337.0% | 0.00% | – |
| Q1 2021 | $5,000 | – | 481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 1,827,478 | $2,696,000 | 2.05% |
| Perceptive Advisors | 14,869,915 | $21,933,000 | 0.44% |
| RTW INVESTMENTS, LP | 4,275,722 | $6,307,000 | 0.13% |
| ArchPoint Investors | 128,750 | $190,000 | 0.07% |
| Orbimed Advisors | 283,217 | $418,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 159,000 | $235,000 | 0.01% |
| Walleye Capital LLC | 93,533 | $138,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 158,875 | $234,000 | 0.00% |
| Renaissance Technologies | 340,500 | $502,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 2,324 | $3,000 | 0.00% |